The lower prevalence rates in the Korean study compared to our study could be explained by study subjects’ low mean BMI (24.8Kg/ m2), exclusion of those on insulin for diabetes management and exclusion of patients with severe painful neuropathy. The gene discussed is INS; the disease is neuropathy.